Ironwood Pharmaceuticals, Inc. (IRWD)
4.125
-0.16
(-3.85%)
USD |
NASDAQ |
Aug 24, 16:00
4.14
+0.02
(+0.36%)
After-Hours: 20:00
Ironwood Pharmaceuticals Profit Margin (Quarterly) : 45.37% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 45.37% |
| March 31, 2026 | 38.28% |
| December 31, 2025 | -4.77% |
| September 30, 2025 | 32.84% |
| June 30, 2025 | 27.69% |
| March 31, 2025 | -90.87% |
| December 31, 2024 | 2.49% |
| September 30, 2024 | 3.98% |
| June 30, 2024 | -0.91% |
| March 31, 2024 | -5.56% |
| December 31, 2023 | -1.48% |
| September 30, 2023 | 12.26% |
| June 30, 2023 | -1.01K% |
| March 31, 2023 | 43.93% |
| December 31, 2022 | 45.59% |
| September 30, 2022 | 46.32% |
| June 30, 2022 | 38.14% |
| March 31, 2022 | 39.78% |
| December 31, 2021 | 35.32% |
| September 30, 2021 | 53.83% |
| June 30, 2021 | |
| March 31, 2021 | 44.94% |
| December 31, 2020 | 37.03% |
| September 30, 2020 | 33.27% |
| June 30, 2020 | 28.18% |
| Date | Value |
|---|---|
| March 31, 2020 | 4.18% |
| December 31, 2019 | 37.89% |
| September 30, 2019 | 15.74% |
| June 30, 2019 | 12.02% |
| March 31, 2019 | -31.79% |
| December 31, 2018 | 6.41% |
| September 30, 2018 | -231.1% |
| June 30, 2018 | -29.76% |
| March 31, 2018 | -62.39% |
| December 31, 2017 | 12.83% |
| September 30, 2017 | -37.20% |
| June 30, 2017 | -67.96% |
| March 31, 2017 | -100.6% |
| December 31, 2016 | -15.44% |
| September 30, 2016 | -50.23% |
| June 30, 2016 | -39.93% |
| March 31, 2016 | -20.13% |
| December 31, 2015 | -26.33% |
| September 30, 2015 | -119.8% |
| June 30, 2015 | -173.1% |
| March 31, 2015 | -114.8% |
| December 31, 2014 | -98.88% |
| September 30, 2014 | -248.2% |
| June 30, 2014 | -882.4% |
| March 31, 2014 | -339.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie, Inc. | 21.21% |
| Rigel Pharmaceuticals, Inc. | 21.97% |
| Marker Therapeutics, Inc. | -- |
| Verastem, Inc. | -86.51% |
| Theriva Biologics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 34.99% |
| Return on Invested Capital | 41.21% |
| Gross Profit Margin (Quarterly) | 99.60% |
| Operating Margin (Quarterly) | 70.16% |
| Return on Net Operating Assets | 119.0% |